TriSalus Life Sciences (TLSI) Gains from Investment Securities (2022 - 2025)
TriSalus Life Sciences (TLSI) reported Gains from Investment Securities of $2.4 million for Q4 2025, down 80.41% on a YoY basis from $12.4 million in Q4 2024, and up 195.88% quarter-over-quarter from -$2.5 million in Q3 2025.
TriSalus Life Sciences (TLSI) Gains from Investment Securities (2022 - 2025) Analysis & Trends
TriSalus Life Sciences has reported Gains from Investment Securities for 4 years, with the latest figure at $2.4 million in Q4 2025.
- For the quarter ending Q4 2025, Gains from Investment Securities fell 80.41% year-over-year to $2.4 million; the trailing twelve-month figure through Mar 2026 stood at -$804000.0 (up 78.23% YoY), and the FY2025 full-year result was $16000.0, down 94.56% from the prior year.
- Gains from Investment Securities for Q4 2025 stood at $2.4 million, up from -$2.5 million in the prior quarter.
- The five-year high for Gains from Investment Securities was $12.4 million in Q4 2024, with the low at -$19.9 million in Q3 2023.
- Historically, Gains from Investment Securities has averaged -$1.7 million across 4 years, with a median of -$339000.0 in 2023.
- Annual changes were most pronounced in 2023 — Gains from Investment Securities tumbled 443.92% — and 2024, when it jumped 20491.67%.
- TriSalus Life Sciences' Gains from Investment Securities stood at $50000.0 in 2022, then rose by 20.0% to $60000.0 in 2023, then jumped by 20491.67% to $12.4 million in 2024, then plunged by 80.41% to $2.4 million in 2025.
- The last three Gains from Investment Securities figures came in at $2.4 million (Q4 2025), -$2.5 million (Q3 2025), and -$700000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 157.80 Bn | 151.14 Bn | 6.27 Bn |
| 2 | Stryker | 115.54 Bn | 112.66 Bn | 3.81 Bn |
| 3 | Medtronic | 103.44 Bn | 95.27 Bn | 5.76 Bn |
| 4 | Boston Scientific | 72.38 Bn | 71.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.76 Bn | 46.09 Bn | 1.29 Bn |
| 6 | Dexcom | 29.53 Bn | 28.42 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 29.51 Bn | 27.44 Bn | 1.98 Bn |
| 8 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 9 | Steris | 20.69 Bn | 20.27 Bn | 697.10 Mn |
| 10 | TriSalus Life Sciences | 166.47 Mn | 109.92 Mn | 7.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.42 Mn |
| Dec 31, 2025 | 2.42 Mn |
| Sep 30, 2025 | -2.52 Mn |
| Sep 30, 2025 | -2.52 Mn |
| Jun 30, 2025 | -700,000.00 |
| Jun 30, 2025 | -700,000.00 |
| Dec 31, 2024 | 12.36 Mn |
| Dec 31, 2024 | 12.36 Mn |
| Sep 30, 2024 | -2.36 Mn |
| Sep 30, 2024 | -2.36 Mn |
| Jun 30, 2024 | -13.69 Mn |
| Jun 30, 2024 | -13.69 Mn |
| Dec 31, 2023 | 60,000.00 |
| Dec 31, 2023 | 60,000.00 |
| Sep 30, 2023 | -19.90 Mn |
| Sep 30, 2023 | -19.90 Mn |
| Mar 31, 2023 | 22,000.00 |
| Mar 31, 2023 | 22,000.00 |
| Dec 31, 2022 | 50,000.00 |
| Dec 31, 2022 | 50,000.00 |